2024 ACC Expert Consensus Decision Pathway for Treatment of Heart Failure With Reduced Ejection Fraction

🏆 Top 10📊 OpenAlex

Most Cited Paper

in Heart Failure Treatment and Management

18 Months Post-Publication

Class of 2026

“2024 ACC Expert Consensus Decision Pathway for Treatment of Heart Failure With Reduced Ejection Fraction”

AuthorsThomas M Maddox et al.

Thomas M Maddox

JournalJournal of the American College of Cardiology

Saint Luke's Mid America Heart Institute

Citations129

DOI10.1016/j.jacc.2023.12.024

A research intelligence initiative by Pepkio

pri.pepkio.com/top-papers/heart-failure-treatment-and-management/2026/

Topics

Heart failure with reduced ejection fraction · Guideline-Directed Medical Therapy · Expert Consensus Decision Pathway · Beta-blockers · ACE inhibitors · Angiotensin receptor-neprilysin inhibitor · Mineralocorticoid receptor antagonists · SGLT2 inhibitors · Angiotensin receptor blockers · Sequencing of Medical Therapy · Left ventricular ejection fraction · Cardiac remodeling · Neurohormonal Activation · Device therapy · Cardiac resynchronization therapy · Implantable cardiac device · Clinical decision-making · Comorbidity Management · Renal Function Monitoring · Hyperkalemia · Diuretic Therapy · Ivabradine · Hydralazine-Isosorbide Dinitrate · Patient-Centered Care · Risk stratification · Heart failure hospitalization · Drug Titration · Multidisciplinary Heart Failure Team · Health disparities in heart failure · Shared Decision-Making

Share on X

Cite this ranking

Pepkio Research Index (PRI). Topics and Trends in Most Cited Heart Failure Treatment and Management Papers, Class of 2026. https://pri.pepkio.com/top-papers/heart-failure-treatment-and-management/2026. Accessed 2026-07-13.

Zheng Su, Tinsley Li, Thematic Shifts in Early-High-Impact Cancer Genomics and Diagnostics Research: A Bibliometric and Semantic Analysis. bioRxiv 2026.07.04.736459; doi: https://doi.org/10.64898/2026.07.04.736459